Communicating the risk reduction achieved by cholesterol reducing drugs

被引：66

作者：

Skolbekken, JA ^{[1
]}

机构：

[1] Univ Tromso, Dept Psychol, N-9037 Tromso, Norway

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1998年 / 316卷 / 7149期

关键词：

D O I：

10.1136/bmj.316.7149.1956

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1956 / 1958

页数：3

共 23 条

[1] INFLUENCE OF METHOD OF REPORTING STUDY RESULTS ON DECISION OF PHYSICIANS TO PRESCRIBE DRUGS TO LOWER CHOLESTEROL CONCENTRATION [J].

BUCHER, HC ;

WEINBACHER, M ;

GYR, K .

BRITISH MEDICAL JOURNAL, 1994, 309 (6957) :761-764

[2]

Calman KC, 1996, BRIT MED J, V313, P799

[3] THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT [J].

COOK, RJ ;

SACKETT, DL .

BRITISH MEDICAL JOURNAL, 1995, 310 (6977) :452-454

[4]

Cranney M, 1996, BRIT J GEN PRACT, V46, P661

[5] Chronic infections and coronary heart disease: is there a link? [J].

Danesh, J ;

Collins, R ;

Peto, R .

LANCET, 1997, 350 (9075) :430-436

[6] EVIDENCE BASED PURCHASING - UNDERSTANDING RESULTS OF CLINICAL-TRIALS AND SYSTEMATIC REVIEWS [J].

FAHEY, T ;

GRIFFITHS, S ;

PETERS, TJ .

BRITISH MEDICAL JOURNAL, 1995, 311 (7012) :1056-1059

[7] ABSOLUTELY RELATIVE - HOW RESEARCH RESULTS ARE SUMMARIZED CAN AFFECT TREATMENT DECISIONS [J].

FORROW, L ;

TAYLOR, WC ;

ARNOLD, RM .

AMERICAN JOURNAL OF MEDICINE, 1992, 92 (02) :121-124

[8]

HEDEVIK I, 1994, TIDSSKR NOR LAERGERF, V114, P1709

[9]

HOLLNAGEL H, 1996, PRACTICUS, V116, P237

[10] REDUCING THE RISK OF CORONARY EVENTS - EVIDENCE FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) [J].

KJEKSHUS, J ;

PEDERSEN, TR .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (09) :C64-C68

← 1 2 3 →